Meeting
2017 Genitourinary Cancers Symposium
Antigen spread (AgS) after sipuleucel-T (sip-T): A cross-trial comparison of 4 sip-T clinical trials of patients (pts) with prostate cancer (PC).
Authors
Lawrence Fong
University of California, San Francisco, San Francisco, CA
Lawrence Fong , Eric Jay Small , Daniel Peter Petrylak , David I. Quinn , Emmanuel S. Antonarakis , Adam S. Kibel , Nancy N. Chang , Harini Kandadi , Nadeem Anwar Sheikh , Charles G. Drake
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Clinical Trial Registration Number
NCT01431391; NCT00065442; NCT01487863; NCT01981122
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 143)
DOI
10.1200/JCO.2017.35.6_suppl.143
Abstract #
143
Poster Bd #
E21
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Immunogenicity of sipuleucel-T (Sip-T) in abiraterone (Abi)/enzalutamide (Enz) sensitive and resistant metastatic castrate-resistant prostate cancer (mCRPC).
First Author: Eric Jay Small
Poster
2017 Genitourinary Cancers Symposium
Boosting long-term immune responses to sipuleucel-T (sip-T) by retreatment of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Tomasz M. Beer
Poster
2014 Genitourinary Cancers Symposium
Antigen spread and survival with sipuleucel-T in patients with advanced prostate cancer.
First Author: Charles G. Drake
Poster
2023 ASCO Genitourinary Cancers Symposium
Racial differences in survival and healthcare resource utilization among Medicaid-insured adults with metastatic castration-resistant prostate cancer.
First Author: Maral DerSarkissian